Floatz logo

Roflumilast

Amnestic Mild Cognitive Disorder

Maastricht University Medical CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Amnestic Mild Cognitive Disorder cohort.

Asset / SponsorPhaseRating
PITTSBURGH COMPOUND B UNLABELLED
Mayo Clinic
N/AD
FLORTAUCIPIR
Mayo Clinic
N/AD

Same molecule, other indications

Roflumilast is also rated in:

polycystic ovary syndromeDormant
BB
Indicative ·
69 / 100
View asset →
bronchiectasisDormant
BB
Indicative ·
68 / 100
View asset →
chronic obstructive pulmonary diseaseDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →